Grow Therapy Secures $150M Series D at a $3B Valuation — Pioneering the Future of Accessible Mental Healthcare

In a defining moment for digital mental health innovation, Grow Therapy has announced a $150 million Series D funding round, propelling the company to a $3 billion valuation and reinforcing its position as a leader in transforming how therapy is delivered in the United States. This milestone signals strong investor confidence in Grow’s mission to make high-quality, insurance-supported mental healthcare accessible, effective, and scalable nationwide.

Hookline: From Barrier to Breakthrough — How Grow Therapy Is Redefining Mental Healthcare Access and Scale

Mental health care remains out of reach for millions due to fragmented insurance systems, provider shortages, and administrative complexity. Grow Therapy is changing that narrative — linking clients with licensed therapists across both in-person and virtual settings while seamlessly integrating insurance coverage to reduce cost barriers and improve outcomes.

What Is Grow Therapy and Why It Matters

Founded in 2020, Grow Therapy has built a provider-centric platform that connects clients with licensed therapists and psychiatrists who accept insurance, offering both virtual and in-person sessions. The company’s technology also supports clinicians with practice management tools such as scheduling, billing, and administrative workflows, allowing them to focus on care delivery rather than paperwork.

Today, Grow Therapy partners with more than 125 health plans and provides access to approx. 220 million Americans. With a network of over 26,000 providers, the platform has facilitated millions of therapy and medication visits, helping millions find care that fits both clinical needs and insurance coverage.

Series D Funding: $150M and $3B Valuation

March 2026 marked a groundbreaking advancement for Grow Therapy, with the company announcing a $150 million Series D financing round led by TCV and Growth Equity at Goldman Sachs Alternatives. New investors BCI and Menlo Ventures joined existing backers including Sequoia Capital, SignalFire, and Transformation Capital.

This round brings Grow Therapy’s total funding to approximately $328 million and places the company at a $3 billion valuation — underscoring its rapid growth trajectory and the increasing investor appetite for digital health platforms that bridge clinical care and technology.

According to reports, Grow also generates around $1 billion in annual revenue, having reached profitability as early as 2023, underscoring strong unit economics alongside mission-driven growth.

Where the Funding Will Be Directed

Grow Therapy plans to deploy the new capital to:

• Expand partnerships with employers and health systems, creating integrated mental health solutions that span employee benefits and primary care referrals.

• Enhance AI-powered tools and digital experiences that streamline therapy workflows for both clinicians and clients, such as automated administrative support and data-driven insights.

• Strengthen support for providers, helping independent therapists grow and manage their practices with less administrative friction.

Grow’s broader strategy includes integrating mental health care more deeply into standard healthcare delivery systems, enabling smoother referral pathways and improving continuity of care from screening to treatment.

Impact at Scale: Delivering Mental Healthcare Across America

By enabling both virtual and face-to-face care backed by insurance, Grow Therapy has helped eliminate longstanding barriers in the mental health system — such as high out-of-pocket costs and limited provider access.

The platform’s rapid growth reflects a system under strain and a rising demand for accessible mental health services. In 2025 alone, the company facilitated millions of appointments and earned high satisfaction scores from clients — with the majority recommending the service to others.

Grow’s expansion into employer mental health benefits also addresses a critical gap: many workplace programs fall short of ensuring ongoing therapy access due to insurance limits or lack of integrated care pathways. Grow’s model connects employer programs with insurance-covered therapy services, improving continuity and outcomes.

A New Era in Digital Mental Health

Grow Therapy’s latest funding round comes amid a broader resurgence of investment in digital mental health platforms. Compared to peers like Headway, Alma, and Talkiatry — all of which have also raised significant capital — Grow stands out for its insurance-first approach and strong partnerships with health plans, employers, and primary care networks, underscoring its scalability and system-wide impact.

The company’s focus on sustainable growth — rather than a rush to public markets — reflects a strategic commitment to building a robust infrastructure that’s deeply embedded in how behavioral care is delivered in the U.S.

Conclusion: Leading the Transformation of Mental Healthcare Delivery

Grow Therapy’s $150 million Series D raise and $3 billion valuation mark a significant inflection point in the digital mental health space. With a unique mix of technology, clinical integration, and insurance compatibility, the company is redefining what it means to deliver effective, affordable mental health care at scale.

As mental health continues to climb the priority ladder for individuals, employers, and healthcare systems alike, Grow Therapy’s comprehensive and scalable model positions it as a central player in shaping the future of accessible care — one therapy session at a time.